丙戊酸钠联合奥卡西平治疗癫痫对患者炎性因子及疗效的影响

doi:10.3969/j.issn.1000-8535.2024.08.016

摘要/Abstract

摘要： 目的探讨丙戊酸钠联合奥卡西平治疗癫痫的疗效及其对患者炎性因子的影响。方法选择2022年1月—2023年1月医院接收的100例癫痫患者进行研究,电脑随机编号奇偶数分为两组各50例,对照组采取丙戊酸钠治疗,观察组采取丙戊酸钠联合奥卡西平治疗,评价并比较两组治疗效果、神经因子、炎症因子、免疫功能、认知功能及生活质量,观察不良反应发生率。结果观察组和对照组的治疗有效分别为47例（94.00%）、39例（78.00%）,观察组治疗有效率高于对照组（χ²=5.315,P=0.02）。治疗后,观察组的脑源性神经营养因子（195.33±18.29）pg/mL、神经生长因子（594.69±54.45）ng/mL水平高,肿瘤坏死因子-α（4.12±1.07）pg/mL、IL-1β（3.48±0.79）pg/mL、IL-6（53.44±3.63）pg/mL水平比对照组（150.68±15.27）pg/mL、（542.46±45.56）ng/mL、（6.35±1.27）pg/mL、（4.35±0.93）pg/mL、（63.02±3.81）pg/mL低（t=13.250、5.201、9.495、5.041、12.872,P<0.05）。治疗后,观察组的IgM（1.02±0.12）g/L、IgG（10.02±1.22）g/L、IgA（2.10±0.22）g/L比对照组（1.13±0.14）g/L、（11.68±1.57）g/L、（2.65±0.31）g/L更高（t=4.218、5.903、10.230,P<0.05）。治疗后,观察组的蒙特利尔认知量表（27.78±2.15）分、日常生活活动量表（71.88±6.45）分、癫痫患者生活质量评定量表-31（82.65±8.25）分比对照组（25.33±2.01）分、（65.65±5.54）分、（74.05±7.37）分更高（t=5.886、5.181、5.497,P<0.05）。观察组、对照组发生不良反应组间比较差异无统计学意义（χ²=1.010,0.343,1.010,1.010,1.010,P均>0.05）。结论丙戊酸钠联合奥卡西平治疗癫痫患者可取得良好的疗效,控制癫痫症状,改善神经因子、认知功能,增强免疫功能,控制炎症因子,而且不良反应少,利于生活质量提高。

关键词: 癫痫, 丙戊酸钠, 奥卡西平, 炎性因子, 免疫功能, 认知功能

Abstract: Objective To investigate the effect of sodium valproate combined with oxcarbazepine in the treatment of epilepsy and its influence on inflammatory factors．Methods From January 2022 to January 2023,100 patients with epilepsy admitted to our hospital were selected and randomly divided into two groups,50 cases in each group．The control group was treated with sodium valproate,and the observation group was treated with sodium valproate combined with oxcarbazepine．The therapeutic effect,neurological factors,inflammatory factors,immune function,cognitive function and quality of life were evaluated and compared between the two groups,and the incidence of adverse reactions was observed．Results The effective rate of the observation group and the control group were 94.00%（47 cases）and 78.00%（39 cases）,respectively．The effective rate of the observation group was higher than that of the control group（χ²=5.315,P=0.02）．After treatment,the levels of brain-derived neurotrophic factor（195.33±18.29）pg/mL and nerve growth factor（594.69±54.45）ng/mL in the observation group were higher than those in the control group．The levels of tumor necrosis factor-α（4.12±1.07）pg/mL,IL-1β（3.48±0.79）pg/mL,IL-6（53.44±3.63）pg/mL in the control group were（150.68±15.27）pg/mL,（542.46±45.56）ng/mL,（6.35±1.27）pg/mL,（4.35±0.93）pg/mL,（63.02±3.81）pg/mL（t=13.250,5.201,9.495,5.041,12.872,P<0.05）． After treatment,the IgM（1.02±0.12）g/L,IgG（10.02±1.22）g/L,IgA（2.10±0.22）g/L were higher than those in the control group（1.13±0.14）g/L,（11.68±1.57）g/L,（2.65±0.31）g/L（t=4.218,5.903,10.230,P<0.05）．After treatment,the scores of Montreal Cognitive Scale（27.78±2.15）,Activities of Daily Living Scale（71.88±6.45）and Quality of Life in Epilepsy Scale 31（82.65±8.25）in the observation group were higher than those in the control group（25.33±2.01）,（65.65±5.54）and（74.05±7.37）（t=5.886,5.181,5.497,P<0.05）．There was no significant difference in adverse reactions between the observation group and the control group（χ²=1.010,0.343,1.010,1.010,1.010,all P>0.05）．Conclusions Sodium valproate combined with oxcarbazepine in the treatment of patients with epilepsy can achieve good curative effect,control epilepsy symptoms,improve neurological factors,cognitive function,enhance immune function,control inflammatory factors,with less adverse reactions,conducive to improve the quality of life．

Key words: epilepsy, sodium valproate, oxcarbazepine, inflammatory factors, immune function, cognitive function

李荣传, 陈海默, 庄金红. 丙戊酸钠联合奥卡西平治疗癫痫对患者炎性因子及疗效的影响[J]. 广州医药, 2024, 55(8): 923-928.

LI Rongchuan, CHEN Haimo, ZHUANG Jinhong. To investigate the effect of sodium valproate combined with oxcarbazepine on inflammatory factors and efficacy in patients with epilepsy[J]. Guangzhou Medical Journal, 2024, 55(8): 923-928.

参考文献

[1] 蒋洁云,陆旭东.左乙拉西坦治疗老年癫痫的疗效及对患者脑电图和炎性因子的影响[J].中国老年学杂志,2023,43(11):2687-2690.
[2] 吴桥. 丙戊酸钠对难治性癫痫患者神经因子及炎性因子水平的影响[J].临床合理用药,2023,16(16):55-58.
[3] 贾文杰,李飞,吴静.左乙拉西坦联合丙戊酸钠对癫痫患者血清炎性因子及癫痫发作的影响[J].反射疗法与康复医学,2023,4(6):106-108,116.
[4] 李世绰,洪震.临床诊疗指南.癫痫病分册[M].北京:人民卫生出版社,2015.
[5] 邵凌云,陈后勤,汪文兵,等.左乙拉西坦、苯妥英钠和丙戊酸钠对老年癫痫持续状态及实验室指标的影响[J].中国老年学杂志,2023,43(15):3757-3759.
[6] 段志文,聂丹丹,兰婷.癫痫患者疾病进展恐惧水平及其相关影响因素分析[J].广州医药,2023,54(11):91-94,104.
[7] 王娇. 丙戊酸钠联合奥卡西平治疗癫痫的临床疗效及对炎性因子的影响[J].中国医药指南,2023,21(2):103-105.
[8] 代洪媛. 奥卡西平联合丙戊酸钠治疗青年难治性部分性癫痫对患者认知功能的影响[J].当代医药论丛,2020,18(24):109-111.
[9] 陈毓茜,李满连.奥卡西平单用及合用其他抗癫痫药物治疗癫痫部分性发作的疗效研究[J].吉林医学,2021,42(1):152-154.
[10] 张晓毅,许莉.丙戊酸钠、奥卡西平联合激素与穴位针刺治疗急性脑动脉炎诱发癫痫的临床效果[J].临床医学,2020,40(7):65-67.
[11] 田丽,胡佳.探讨丙戊酸钠联合奥卡西平治疗癫痫的临床疗效和对炎性因子的影响[J].四川解剖学杂志,2019,27(3):13-15.
[12] 贝宁,贝筝,陈怡.癫痫宁片联合奥卡西平治疗癫痫的临床研究[J].现代药物与临床,2023,38(9):2227-2231.
[13] 金丹,张良兵,刘李军,等.丙戊酸钠联合卡马西平治疗难治性癫痫临床效果及对脑电图、抗谷氨酸脱羧酶抗体、抗核抗体影响[J].临床军医杂志,2023,51(7):757-760.
[14] 王继芬,肖春霞,饶丹,等.奥卡西平与卡马西平治疗贵州少数民族儿童部分性癫痫的对比研究[J].医药论坛杂志,2020,41(6):53-55,60.
[15] 杨亚丽,敬韶辉.定痫汤联合奥卡西平治疗癫痫患儿的效果及对认知功能的影响[J].癫痫与神经电生理学杂志,2023,32(3):157-161.
[16] 张东林,李爱华.左乙拉西坦联合奥卡西平治疗卒中后继发癫痫患者的效果分析[J].癫痫与神经电生理学杂志,2023,32(5):295-300.
[17] 白艳敏,杜开先,陈豪,等.Griffiths精神发育评估量表中文版评估丙戊酸钠、奥卡西平及左乙拉西坦对癫痫患儿不同能区发育影响的研究[J].中国全科医学,2023,26(23):2918-2922.
[18] 吴玲玲,林彩梅.丙戊酸钠联合奥卡西平治疗癫痫患儿的疗效观察[J].深圳中西医结合杂志,2022,32(19):61-63.
[19] 罗辉,潘鑫,代志远,等.奥卡西平联合丙戊酸钠对脑梗死后继发癫痫患者疗效及血液流变学的影响[J].中国当代医药,2023,30(10):118-121.
[20] 杨艳萍,何蝶,周振,等.血清SIRT1表达对丙戊酸钠治疗癫痫患者疗效的影响[J].中国药房,2022,33(23):2886-2890.
[21] 王春霞,许飞.拉考沙胺联合奥卡西平治疗癫痫临床评价[J].中国药业,2022,31(20):98-100.
[22] 彭向玉,刘莉琼,李晶,等.奥卡西平联合丙戊酸钠治疗癫痫部分性发作的效果研究[J].上海医药,2022,43(12):29-31,35.
[23] 马林楠,刘卓,吴芳,等.奥卡西平+维生素B6+左乙拉西坦治疗癫痫患儿的效果及对其视频脑电图的影响[J].海南医学,2023,34(10):1432-1435.
[24] 张超男,郭红,朱琦,等.小剂量丙戊酸联合奥卡西平治疗老年癫痫46例疗效分析[J].中国临床保健杂志,2020,23(1):94-97.
[25] 孙婷,李晓琳,宋述环.低频重复经颅磁刺激联合丙戊酸钠治疗癫痫效果及对氧化-抗氧化系统的调节效应[J].脑与神经疾病杂志,2023,31(12):741-745.